Neoadjuvant Immunotherapy Shows Promise in pMMR/MSS Rectal Cancer

Combining neoadjuvant therapy with immunotherapy in patients with mismatched repair-proficient/microsatellite stable (pMMR/MSS) rectal cancer yielded high pathological and clinical response rates, excellent surgical outcomes, and a manageable…